| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6846944
[patent_doc_number] => 20030166111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/174569
[patent_app_country] => US
[patent_app_date] => 2002-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61107
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166111.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174569
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174569 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 17, 2002 | Abandoned |
Array
(
[id] => 6804945
[patent_doc_number] => 20030232339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Human TRPCC cation channel and uses'
[patent_app_type] => new
[patent_app_number] => 10/167631
[patent_app_country] => US
[patent_app_date] => 2002-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19513
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232339.pdf
[firstpage_image] =>[orig_patent_app_number] => 10167631
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/167631 | Human TRPCC cation channel and uses | Jun 12, 2002 | Abandoned |
Array
(
[id] => 1338654
[patent_doc_number] => 06589745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-08
[patent_title] => 'CIF130 inhibits cell cycle progression'
[patent_app_type] => B2
[patent_app_number] => 10/147268
[patent_app_country] => US
[patent_app_date] => 2002-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 17619
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/589/06589745.pdf
[firstpage_image] =>[orig_patent_app_number] => 10147268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/147268 | CIF130 inhibits cell cycle progression | May 14, 2002 | Issued |
Array
(
[id] => 6176500
[patent_doc_number] => 20020155606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Method for regulating gene expression'
[patent_app_type] => new
[patent_app_number] => 10/127265
[patent_app_country] => US
[patent_app_date] => 2002-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8942
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155606.pdf
[firstpage_image] =>[orig_patent_app_number] => 10127265
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/127265 | Method for regulating gene expression | Apr 21, 2002 | Abandoned |
Array
(
[id] => 5787190
[patent_doc_number] => 20020160463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Phagemid for antibody screening'
[patent_app_type] => new
[patent_app_number] => 10/117057
[patent_app_country] => US
[patent_app_date] => 2002-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3728
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160463.pdf
[firstpage_image] =>[orig_patent_app_number] => 10117057
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/117057 | Phagemid for antibody screening | Apr 7, 2002 | Issued |
Array
(
[id] => 1223545
[patent_doc_number] => 06699691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-03-02
[patent_title] => 'Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast'
[patent_app_type] => B2
[patent_app_number] => 10/116993
[patent_app_country] => US
[patent_app_date] => 2002-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11360
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/699/06699691.pdf
[firstpage_image] =>[orig_patent_app_number] => 10116993
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/116993 | Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast | Apr 4, 2002 | Issued |
Array
(
[id] => 6730059
[patent_doc_number] => 20030186249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Human TARPP genes and polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/112372
[patent_app_country] => US
[patent_app_date] => 2002-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17666
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186249.pdf
[firstpage_image] =>[orig_patent_app_number] => 10112372
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/112372 | Human TARPP genes and polypeptides | Mar 31, 2002 | Abandoned |
| 09/980548 | Promoter-transactivator system for inducible high-level mammalian gene expression with the option of cell growth control | Mar 26, 2002 | Abandoned |
Array
(
[id] => 6646206
[patent_doc_number] => 20030104356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Compounds and methods for treating and screening viral reactivation'
[patent_app_type] => new
[patent_app_number] => 10/108164
[patent_app_country] => US
[patent_app_date] => 2002-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21673
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104356.pdf
[firstpage_image] =>[orig_patent_app_number] => 10108164
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/108164 | Compounds and methods for treating and screening viral reactivation | Mar 25, 2002 | Abandoned |
| 10/048285 | Method for screening molecules intended for the treatment of huntington's disease | Mar 11, 2002 | Abandoned |
Array
(
[id] => 1245524
[patent_doc_number] => 06677126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-13
[patent_title] => 'Antibody for human translational regulator'
[patent_app_type] => B2
[patent_app_number] => 10/096703
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 19265
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677126.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096703
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096703 | Antibody for human translational regulator | Mar 11, 2002 | Issued |
Array
(
[id] => 6562403
[patent_doc_number] => 20020164801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Human and mammalian DNA replication origin consensus sequences'
[patent_app_type] => new
[patent_app_number] => 10/092140
[patent_app_country] => US
[patent_app_date] => 2002-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10003
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10092140
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/092140 | Human and mammalian DNA replication origin consensus sequences | Mar 5, 2002 | Abandoned |
Array
(
[id] => 951442
[patent_doc_number] => 06960647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-01
[patent_title] => 'Stat3 protein fragments and mutants'
[patent_app_type] => utility
[patent_app_number] => 10/090185
[patent_app_country] => US
[patent_app_date] => 2002-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 19
[patent_no_of_words] => 12773
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/960/06960647.pdf
[firstpage_image] =>[orig_patent_app_number] => 10090185
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/090185 | Stat3 protein fragments and mutants | Mar 3, 2002 | Issued |
| 90/006226 | HUMAN CELL-LINES | Feb 24, 2002 | Issued |
Array
(
[id] => 699652
[patent_doc_number] => 07067617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Zinc finger binding domains for nucleotide sequence ANN'
[patent_app_type] => utility
[patent_app_number] => 10/080100
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 34
[patent_no_of_words] => 13490
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067617.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080100
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080100 | Zinc finger binding domains for nucleotide sequence ANN | Feb 20, 2002 | Issued |
Array
(
[id] => 6527839
[patent_doc_number] => 20020192753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Method of making proteins in transformed yeast cells'
[patent_app_type] => new
[patent_app_number] => 10/077260
[patent_app_country] => US
[patent_app_date] => 2002-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4995
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192753.pdf
[firstpage_image] =>[orig_patent_app_number] => 10077260
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/077260 | Method of making proteins in transformed yeast cells | Feb 13, 2002 | Abandoned |
Array
(
[id] => 6176159
[patent_doc_number] => 20020155540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Method to reduce transcriptional interference between tandem genes'
[patent_app_type] => new
[patent_app_number] => 10/074744
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16282
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155540.pdf
[firstpage_image] =>[orig_patent_app_number] => 10074744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/074744 | Method to reduce transcriptional interference between tandem genes | Feb 12, 2002 | Abandoned |
Array
(
[id] => 6472593
[patent_doc_number] => 20020151457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'FRA -1 expression in brain cancer'
[patent_app_type] => new
[patent_app_number] => 10/075499
[patent_app_country] => US
[patent_app_date] => 2002-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17230
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151457.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075499
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075499 | Method for identifying a test compound that modulates expression of a Fra-1 gene in a brain cancer cell | Feb 11, 2002 | Issued |
Array
(
[id] => 757331
[patent_doc_number] => 07015012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-21
[patent_title] => 'Methods of identifying agents that mediate polypeptide aggregation'
[patent_app_type] => utility
[patent_app_number] => 10/470765
[patent_app_country] => US
[patent_app_date] => 2002-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8626
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015012.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470765
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470765 | Methods of identifying agents that mediate polypeptide aggregation | Feb 10, 2002 | Issued |
| 09/913916 | Gcn4-derived expression of heterologous coding sequences and different uses thereof | Jan 21, 2002 | Abandoned |
